Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
Nerandomilast may represent a meaningful addition to the treatment arsenal, offering patients and clinicians a new option for pulmonary fibrosis. A new systematic review and meta-analysis suggests ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
BOSTON, March 25, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...
Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story. Researchers who studied data from ...
Select your location to view local American Lung Association events and news near you.
Pharmac has announced it will fund cystic fibrosis medicines Trikafta and Alyftrek for children of all ages from Wednesday. It's currently only funded for those aged six and older. Pharmac consulted ...
Trouble sleeping? Nowadays, there's a long list of sleep hacks you can try, from TikTok's sleepy girl mocktail to listening to people crunching foil in an ASMR video. But if sleep continues to elude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results